Skip to content
Biodatica
Start free

Investigator

Reza Dana

SCHEPENS EYE RESEARCH INSTITUTE · funded by NEI

Companies
2

Resolved onto their grants.

Grants
4

Federal awards on file.

Non-dilutive funding
$1.7M

Summed across those awards.

First award
Aug 1, 2000

Latest Sep 30, 2022.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R01

    The Impact of Donor Diabetes on Corneal Immune Cells and Graft Survival

    $419k

    Sep 30, 2022NEISCHEPENS EYE RESEARCH INSTITUTENIH RePORTER · 11175982 (opens the source filing in a new tab)

  2. R01

    Immunopathogenic Mechanisms of Dry Eye Disease

    $588k

    Sep 30, 2010NEISCHEPENS EYE RESEARCH INSTITUTENIH RePORTER · 11237037 (opens the source filing in a new tab)

  3. K12

    Harvard-Vision Clinical Scientist Development Program

    $4k

    Sep 30, 2004NEIMASSACHUSETTS EYE AND EAR INFIRMARYNIH RePORTER · 11094691 (opens the source filing in a new tab)

  4. R01

    Mechanisms of Sensitization in High Risk Corneal Grafts

    $671k

    Aug 1, 2000NEISCHEPENS EYE RESEARCH INSTITUTENIH RePORTER · 11139638 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources